Reuters logo
BRIEF-Orexigen Therapeutics Q2 loss per share $2.00
2017年8月8日 / 晚上8点32分 / 1 个月前

BRIEF-Orexigen Therapeutics Q2 loss per share $2.00

Aug 8 (Reuters) - Orexigen Therapeutics Inc

* Orexigen Therapeutics announces second quarter 2017 financial results

* Q2 loss per share $2.00

* Orexigen Therapeutics - qtrly revenue $23.4 million versus $7.8 million; as of June 30, co had $86.6 million in cash, & cash equivalents and marketable securities​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below